Mental Disorders, Severe Clinical Trial
— TACTICOfficial title:
Transmural Collaborative Care Model for Cardiovascular Risk Management (CVRM) and Medication Review for Patients Using Antipsychotics: a Cluster Randomised Stepped Wedge Trial
Currently, monitoring of usage and effects of antipsychotic treatment and cardiovascular risk screening in patients with severe mental illness or antipsychotic treatment is not sufficient. A transmural collaborative care model for cardiovascular risk management and medication review for patients using atypical antipsychotics in general practice (TACTIC) was developed. This trial aims to assess the effectiveness of TACTIC regarding predicted cardiovascular risk and mental quality of life.
Status | Recruiting |
Enrollment | 480 |
Est. completion date | November 1, 2024 |
Est. primary completion date | November 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years to 84 Years |
Eligibility | Inclusion Criteria: - using atypical antipsychotic medication for at least 3 months at baseline - the atypical antipsychotic medication is prescribed by the general practitioner - a 10-year cardiovascular risk of at least 5% (as measured with QRISK3 score) at baseline Exclusion Criteria: - diagnosis of dementia or organic psychosis - diagnosis of cardiovascular disease (acute myocardial infarction, acute coronary syndrome, heart failure, ischemic stroke, transient ischemic attack, peripheral artery disease, aortic aneurysm or a revascularization procedure, i.e. percutaneous coronary intervention or coronary artery bypass grafting) |
Country | Name | City | State |
---|---|---|---|
Netherlands | Radboud university medical centre, Dept. Primary and Community Care | Nijmegen |
Lead Sponsor | Collaborator |
---|---|
Radboud University Medical Center | Onze Huisartsen BV., ZonMw: The Netherlands Organisation for Health Research and Development |
Netherlands,
Bischoff EWMA, Jakobs KM, Assendelft WJJ. Cardiovascular risk management in patients using antipsychotics: it is time to take action. BMC Med. 2020 Nov 2;18(1):339. doi: 10.1186/s12916-020-01811-7. No abstract available. — View Citation
Jakobs K, Lautan L, Lucassen P, Janzing J, van Lieshout J, Biermans MCJ, Bischoff EWMA. Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners. Eur J Gen Pract. 2022 Dec;28(1):191-199. doi: 10.1080/13814788.2022.2092093. — View Citation
Jakobs KM, Posthuma A, de Grauw WJC, Schalk BWM, Akkermans RP, Lucassen P, Schermer T, Assendelft WJJ, Biermans MJC. Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice. BMC Fam Pract. 2020 Jul 29;21(1):153. doi: 10.1186/s12875-020-01225-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The change in QRISK3 score as measured with the QRISK3 calculator (https://qrisk.org/three/) | The risk score of developing cardiovascular disease over the next 10 years is estimated using the QRISKĀ®3 algorithm (https://qrisk.org/three/), which calculates a person's ten-year risk of cardiovascular disease by taking multiple risk parameters into account. A higher score means a higher risk. Risks may vary between 0% and 100%. The parameter Townsend deprivation score will be set to 0 (as advised by its developers), meaning neither deprived nor affluent, as this score does not apply to the Dutch population. | Measurements at baseline, at 5, 10, 15 and 20 months (depending on the specific wave in the stepped-wedge trial in which follow-up starts) | |
Primary | The change in Mental Health, as measured with the Mental Health Inventory questionnaire | Mental Health is measured using the five-item version of the Mental Health Inventory (MHI) questionnaire. The MHI-5 is a derivative of the 36-item short form (SF-36) health survey, and assesses symptoms of depression and anxiety, loss of behavioural or emotional control, and psychological well-being in the prior four weeks. Scores range from 0 to 100, lower scores are worse, and patients with a score =60 are considered mentally healthy. | Measurements at baseline, at 5, 10, 15 and 20 months (depending on the specific wave in the stepped-wedge trial in which follow-up starts) | |
Secondary | The change in Quality of Life (QoL) as measured with the EuroQuality of Life Five Dimensions (EQ-5D-5L) questionnaire | QoL is measured using the EuroQuality of Life Five Dimensions (EQ-5D-5L) questionnaire, which measures generic quality of life on 5 domains with a 5-point Likert scale. A higher score means a worse healt state in each domain, with a maximum of 5 points. | Measurements at baseline, at 5, 10, 15 and 20 months (depending on the specific wave in the stepped-wedge trial in which follow-up starts) | |
Secondary | The change in Side effects of antipsychotic medication, as measured with the Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS) questionnaire | The side effects of antipsychotic medication is measured using the Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS) questionnaire, which assesses side effects of neuroleptic drugs. It has been designed to enable the client to make the rating themselves but can also be administered by mental health workers if the client is unable to complete it. The scale consists of 41 known side effects of neuroleptics. Each 'side-effect' listed is scored on a five point rating scale of 0 - 4, i.e. 0 = 'Not at all' and 4 = Very much. A higher total score means more side-effects. Maximum total score is 84 | Measurements at baseline, at 5, 10, 15 and 20 months (depending on the specific wave in the stepped-wedge trial in which follow-up starts) | |
Secondary | The change in Client Satisfaction, as measured with the 8-item Client Satisfaction Questionnaire (CSQ-8) | Client Satisfaction with care is measured using the CSQ-8, an 8-item questionnaire using a 4-point Likert scale. The sum of 8 sub-scores about different aspects of received care can vary between 8 and 32. Higher scores mean higher satisfaction. | At 5 months from baseline | |
Secondary | The change in risk score of developing cardiovascular disease over the next 10 years including a Dutch deprivation score | The risk estimation of the QRISK3 score is based on several parameters including the Townsend deprivation score. For the primary outcome the score will be set to 0, as the original score does not apply to the Dutch population. For this secondary outcome the QRISK3 score will be calculated including a Dutch deprivation index. A higher score means a higher risk. Risks may vary between 0% and 100%. | Measurements at baseline, at 5, 10, 15 and 20 months (depending on the specific wave in the stepped-wedge trial in which follow-up starts) | |
Secondary | The change in QRISK3 score as proportion of the maximum achievable change in QRISK3 score | The change in QRISK3 score as a proportion of the maximum achievable change in QRISK3 score is the change in QRISK3 score that has been achieved at the end of follow-up divided by the change in QRISK3 score that could have been achieved when all modifiable risk factors would have been improved. The proportional score may be 1.0 (actual change equals maximum achievable change) or less. | Measurements at baseline baseline at 5, 10, 15 and 20 months (depending on the specific wave in the stepped-wedge trial in which follow-up starts) | |
Secondary | The change in costs related to health care | Costs include health care utilization, such as medication use, visits to the general practice, visits to relevant medical specialists, hospitalisation. Costs will be calculated during follow-up time and will be compared with the same period of time prior to start of follow-up. | 1-20 months (depending on the duration of follow-up which differs between the waves in the stepped-wedge trial. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT05293587 -
Physical Activity to Reduce Diabetes Risk in Serious Mental Illness
|
N/A | |
Active, not recruiting |
NCT05545228 -
The Mouth Matters in Mental Health Study
|
N/A | |
Completed |
NCT04917666 -
Process and Outcomes of Horticultural Therapy for People With Disabilities
|
N/A | |
Recruiting |
NCT04350294 -
Measuring Development of Brain Responses to Vocal Sounds in Babies of Mums With Mental Illness
|
||
Completed |
NCT05564559 -
Multifamily Group Psychoeducation for SUD's in Turkey
|
N/A | |
Active, not recruiting |
NCT05004298 -
Evaluation of an Animal Assisted Therapy Program in People With Mental Illness, and Promotion of Positive Mental Health
|
N/A | |
Recruiting |
NCT05160701 -
Bringing Health Home
|
N/A | |
Recruiting |
NCT04675567 -
The Safety-Net Approach
|
N/A | |
Active, not recruiting |
NCT04881084 -
Exploring Empathy and Compassion Using Digital Narratives
|
N/A | |
Enrolling by invitation |
NCT03884933 -
Large Scale Implementation of Community Based Mental Health Care for People With Severe and Enduring Mental Ill Health in Europe
|
N/A | |
Completed |
NCT03999892 -
Adapted ACHIEVE Curriculum for Community Mental Health Settings
|
N/A | |
Completed |
NCT04612777 -
A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses
|
N/A | |
Completed |
NCT03157557 -
Multidisciplinary Lifestyle-enhancing Treatment for People With Severe Mental Illness in Sheltered Housing Facilities
|
N/A | |
Suspended |
NCT03740139 -
The Police-Mental Health Linkage System
|
N/A | |
Completed |
NCT03855761 -
Testing a Novel Community-based Occupational Therapy Model
|
N/A | |
Recruiting |
NCT05834309 -
Exercise Effects on Health Status in Patients With Severe Mental Illness
|
N/A | |
Completed |
NCT04013932 -
Family Psychoeducation for Adults With Psychotic Disorders in Tanzania
|
N/A | |
Enrolling by invitation |
NCT05457179 -
Physical Activity to Reduce Cardiometabolic Risk in Adults With Serious Mental Illness (PARCS) Study
|
N/A | |
Completed |
NCT04948853 -
Improving Employment Outcomes for Probationers With Mental Illnesses
|
N/A |